Affinity of new anticancer agent, 7-trimethylsilyl-ethyl-10-amino-camptothecin, to membranes and HSA determined by fluorescence spectroscopy methods

• Autorzy: Kruszewski S. , Kruszewska D. M.
• Języki publikacji: EN

Abstrakty

EN

The application of fluorescence anisotropy measurements in determining the properties of camptothecin analogue 7-trimethylsilylethyl-10-amino-camptothecin - a promising anticancer agent - is described in this paper. The fluorescence anisotropy measurements provide useful information about binding of camptothecins to membranes and proteins, including human serum albumin (HSA). Knowledge of these properties is important for potential clinical applications of these agents, and permits to select from camptothecin analogues only those which exhibit desirable properties. An active lactone form of camptothecin in fluids at pH 7.4 hydrolyses and converts into an inactive carboxylate form. The carboxylate form of camptothecin binds easily and irreversibly to HSA. Only free carboxylate form can transform back into lactone, then in the presence of HSA one direction transition occurs (from lactone to carboxylate); therefore in HSA solution, after about two hours, the lactone form almost totaly decays. On the other hand, the camptothecins bound to membranes do not hydrolyse. Fluorescence anisotropy measurements prove that 7-trimethylsilylethyl-10-amino-camptothecin exhibits desirable properties: high affinity of its lactone form to membranes and low affinity of its carboxylate form to HSA. Such properties should ensure high stability of this drug in physiological fluids, including blood.

Słowa kluczowe

EN

camptothecin; silatecan; fluorescence anisotropy; membranes binding; HSA affinity

• Wydawca: Oficyna Wydawnicza Politechniki Wrocławskiej
• Czasopismo: Optica Applicata
• Rocznik: 2008
• Tom: Vol. 38, nr 4
• Strony: 625--633
• Opis fizyczny: Bibliogr. 15 poz.,

Twórcy

autor

Kruszewski S.

autor

Kruszewska D. M.

• Medical Physics Division, Biophysics Department, Collegium Medicum of Nicolaus Copernicus University, ul. Jagiellońska 13, 85-067 Bydgoszcz, Poland

Bibliografia

• [1] WALL M.E., WANI M.C., COOK C.E., PALMER K.H., MCPHAIL A.T., SIM G.A., Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata, Journal of the American Chemical Society 88(16), 1966, pp. 3888–90.
• [2] LIU L.F., DESAI S.D., LI T.K., MAO Y., SUN M., SIM S.P., Mechanism of action of camptothecin, Annals of the New York Academy of Sciences 922, 2000, pp. 1–10.
• [3] KOHN K.W., POMMIER Y., Molecular and biological determinants of the cytotoxic actions of camptothecins, Annals of the New York Academy of Sciences 922, 2000, pp. 11–26.
• [4] MI Z., BURKE T.G., Differential interactions of camptothecin lactone and carboxylate forms with human blood components, Biochemistry 33(34), 1994, pp. 10325–336.
• [5] KRUSZEWSKI S., BURKE T.G., Camptothecins affinity to HSA and membranes determined by fluorescence anisotropy measurements, Optica Applicata, 32(4), 2002, pp. 721–30.
• [6] BOM D., CURRAN D.P., ZHANG J., ZIMMER S.G., BEVINS R., KRUSZEWSKI, S., HOWE J.N., BINGCANG A., LATUS L.J., BURKE T.G., The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity, Journal of Controlled Release 74(1–3), 2001, pp. 325–33.
• [7] CYRANKIEWICZ M, ZIOMKOWSKA B., KRUSZEWSKI S., Fluorescence spectra analysis and fluorescence anisotropy titration methods in determining the hydroxy-camptothecins affinity to membranes, Polish Journal of Environmental Studies 15(4A), 2006, pp. 47–9.
• [8] ZIOMKOWSKA B., CYRANKIEWICZ M., KRUSZEWSKI S., Determination of hydroxycamptothecin affinities to albumin and membranes by steady-state fluorescence anisotropy measurements, Combinatorial Chemistry & High Throughput Screening 10(6), 2007, pp. 486–92.
• [9] ZIOMKOWSKA B., CYRANKIEWICZ M., KRUSZEWSKI S., Hydroxycamptothecin deactivation rates and binding to model membranes and HSA determined by fluorescence spectra analysis, Combinatorial Chemistry & High Throughput Screening 10(6), 2007, pp. 459–65
• [10] KRUSZEWSKI S., BOM D., ZIOMKOWSKA B, CYRANKIEWICZ M., Affinity of new anticancer agent, DB-174, to membranes and HSA determined by fluorescence spectroscopy methods, Optica Applicata 36(2–3), 2006, pp. 199–207.
• [11] Lakowicz J.R., Principles of Fluorescence Spectroscopy, Kluwer Academic/Plenum Publishers, New York 1999.
• [12] BURKE T.G., MISHRA, WANI M.C., WALL M.E., Lipid bilayer partitioning and stability of camptothecin drugs, Biochemistry 32(20), 1993, pp. 5352–64.
• [13] KRUSZEWSKI S., SIUDA R., ZIOMKOWSKA B., CYRANKIEWICZ M., Application of PCA and FA of fluorescence spectra in camptothecin studies, Optica Applicata 33(2–3), 2003, pp. 369–80.
• [14] ZIOMKOWSKA B., KRUSZEWSKI S., SIUDA R., CYRANKIEWICZ M., Deactivation rate of camptothecin determined by factor analysis of steady-state fluorescence and absorption spectra Optica Applicata 36(1), 2006, pp. 137–46.
• [15] KRUSZEWSKI S., CYRANKIEWICZ M., ZIOMKOWSKA B., Biophysical properties of 10-hydroxy-camptothecin determined by fluorescence anisotropy measurements, Polish Journal of Environmental Studies 15(4A), 2006, pp. 69–71.